HAI Solutions Inc

HAI Solutions Inc is a medical device company focused on preventing healthcare-associated infections (HAI) through innovative vascular access and intravenous care solutions. The company develops ultraviolet light-based microbial reduction devices and anesthesia delivery systems targeting contamination in operating rooms, emergency departments, and intensive care units. HAI Solutions' primary platform addresses Hospital Onset Bacteremia (HOB) and microbial contamination (MC) in needleless IV connectors and vascular access lines. The QIKcap System™ is an FDA De Novo-cleared ultraviolet (UVC) light-based microbial reduction device designed for needleless IV connectors—marketed as the first and only FDA-granted solution of its kind. The Multiport Delivery Device™ is a novel anesthesia induction system currently in development and not yet FDA-cleared. HAI Solutions addresses a significant clinical need: over 300 million IV lines are placed annually in the US, with 1 in 31 patients acquiring catheter-related bloodstream infections, costing $15,000–$30,000 per incident. The company serves peripheral, PICC, central vascular access, and dialysis line applications across the healthcare continuum. HAI Solutions holds ISO 13485 certification for medical device quality management and has received patent allowances from the US Patent and Trademark Office for intravenous device technology. The company has won recognition from industry organizations including the AANA (American Association of Nurse Anesthetists) Rm8 iNov8 Pitch Competition and CONNECT SD's Cool Company 2022 award.